FMR1 and fragile X syndrome: Here again, the precise deletion of the FXS disease-causing mutation resulted in the re-activation of FMR1 transcription and demethylation in five out of the nine gene edited hybrid clones, while in FXS iPSCs only one out of the five FXS iPSC gene re-activated clones transcription was successfully restored (8 CpG sites).